Table 1.
Diet/supplement studied | HS study population | Key findings | Reference (first author, year) |
---|---|---|---|
Mediterranean diet (MD) | 41 treatment-naïve patients, 41 control subjects (case–control, cross-sectional) | HS patients had lower adherence to the MD | Barrea, 2019 [11] |
221 patients (cross-sectional) | Higher adherence to a MD was associated with lower disease activity | Fuentes, 2022 [12] | |
35 patients, and 35 matched healthy subjects | Mediterranean diet adherence did not correlate with HS disease severity | Velluzzi, 2022 [14] | |
Low carbohydrate/low dairy | 40 patients (retrospective cohort) | 7/40 patients had considerably improved HS on a low dairy/low carbohydrate diet | Kurzen, 2019 [15] |
47 patients in a personal dairy-free series | 83% of 47 patients undergoing a dairy-free diet had improved symptoms | Danby, 2015 [16] | |
770 patients in anonymous Facebook survey-based study | Of 237 patients, 50.6% reported dairy and 51.1% reported various carbs as symptom exacerbating foods | Fernandez, 2020 [13] | |
High fat diet | 770 patients in anonymous Facebook survey-based study | Of 237 patients, 42.2% identified high fat foods as symptom-exacerbating | Fernandez, 2020 [13] |
Brewer’s yeast-free diet | 12 post-operative patients with IgG reaction to brewer’s yeast and wheat | Brewer’s yeast-free diet for 12 months caused immediate symptom stabilization and lesion regression in all patients | Cannistra, 2013 [24] |
37 patients following a brewer’s and baker’s yeast exclusion diet | Among 37 patients following a yeast-exclusion diet, 70% reported symptom improvement | Aboud, 2020 [25] | |
Zinc | 22 patients treated with 90 mg zinc gluconate per day | Of 22 patients, 8 had a complete remission, and 14 with partial remissions | Brocard, 2007 [27] |
66 patients treated with combination 90 mg zinc gluconate per day and 2% topical triclosan twice daily | Significant reduction in severity of disease severity, erythema and inflammatory nodules | Hessam, 2016 [28] | |
122 patients and 122 controls with serum zinc measured | Low serum zinc found to be more prevalent in HS patients, and associated with severe HS | Poveda, 2018 [29] | |
92 patients treated with zinc and nicotinamide maintenance treatment | Treated patients experienced a significant reduction in acute flares, and longer disease-free survival | Molinelli, 2020 [30] | |
Vitamin D | 16 patients with serum vitamin D measured | Patients had a poor vitamin D status, with 10 having < 30 nmol/L and 2 having < 50 nmol/L | Kelly, 2014 [35] |
14 patients supplemented with vitamin D | Vitamin D supplementation significantly reduced number of nodules at 6 months | Guillet, 2015 [36] | |
250 patients, measuring serum vitamin D at diagnosis before HS treatment | Inverse correlation between vitamin D levels and C-reactive protein | Moltrasio, 2021 [42] | |
110 patients, 110 matched controls with serum vitamin D measured | Patients with HS were more likely to have vitamin D deficiency compared to healthy controls | Seetan, 2022 [37] | |
Homocysteine/vitamin B12 | 26 patients, 26 healthy controls, measuring serum homocysteine | Higher prevalence of hyperhomocysteinemia in HS patients vs controls | Marasca, 2019 [43] |
2 patients with HS and inflammatory bowel disease (IBD) + 10 IBD patients with various suppurative dermatoses | High-dose vitamin B12 prevented recurrence of suppuration in 2 patients with HS and IBD. In 10 additional IBD patients, 6/10 benefitted from high-dose vitamin B12 | Mortimore, 2010 [44] |
HS hidradenitis suppurativa, IBD irritable bowel disease, IgG immunoglobulin G, MD Mediterranean diet